Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
The Vurger Co aim to revolutionise the fast food industry with their 100% plant based burgers. They have run a number of successful pop up shops and are now looking to bring the plant based revolution to London with their first restaurant.
days to go:
Expired
investment:
£299,760
Ripple is a clean energy ownership platform and renewable energy expert which aims at providing people the opportunity to own their own source of low-cost clean power. More than 460 people have pre-registered for Ripple's first wind farms. It has achieved a pre-registration conversion rate of 27% from click-throughs amongst Tesla owners. With the proceeds, Ripple will focus on launching the pilot wind farm project and recruiting a new Tech Team of a Finance Director, and a Business Development Manager. It is also preparing its business costs for the launch of the full-scale project in early 2020.
days to go:
Expired
investment:
£859,787
Fullgreen manufactures a range of healthy food products and aims to make healthy eating easy. Initially launched as Cauli Rice™, this company rebranded itself as Fullgreen to display its joyful and vibrant personality. It operates two dedicated factories and sells its products in the major UK supermarkets and supplies to over 2,000+ US largest retailers. In 3.5 years, it has sold over 5 million pouches. Furthermore, this company has a globally patented process that extends the life of vegetables without the use of any preservatives. Currently, it is raising funds to expand its business and more than double its point of distribution in the next two years. Moreover, it will also invest the fund raised in marketing to help build Fullgreen as a brand and launch two new exciting innovations in new packaging design.
days to go:
Expired
investment:
£743,390
Fireaway pizza orginally started out as a modest pizzeria in south London in 2016, we've expanded to 159 franchises, achieving a remarkable 106% compound annual growth rate in store expansion. With franchise sales reaching £59 million annually, we became debt-free in 2022, boasting an EBITDA of £1.31 million and HQ revenue of £14.5 million in FY23. As a profitable venture, we invite you to join us and be part of our promising growth trajectory.
days to go:
Expired
investment:
£532,336
Aardvark is a company that manufactures dry kibbles for dogs and cats using insects as the source of protein. It has partnered with VC backed insect farm NextProtein. The company claims that its products meet the nutritional needs of pets while creating a smaller environmental footprint than pet food that uses animal meat. It also asserts that insect protein is endorsed by the British Veterinary Association. The company has developed its kibbles to be grain-free, consist of seaweed and other natural ingredients with no fillers. The UK pet food market is poised to grow to £2.9 billion in 2020, and the company aims to be a sustainable manufacturer in this segment. The company requires investment to assist in manufacturing its first batch of pet food, help market its products to pet owners across the UK, and expand into Europe by 2021 and the U.S by 2024.
days to go:
Expired
investment:
£300,290
